# Intarcia Therapeutics, Inc. – FDA Inspection, Aug 3, 2017

Source: https://www.keypedia.com/records/fda_inspections/intarcia-therapeutics-inc/4c500167-8bf5-4977-a32c-576495eb43c0
Source feed: FDA_Inspections

> FDA inspection 1020235 of Intarcia Therapeutics, Inc., August 03, 2017. Classification: Official Action Indicated (OAI). 9 citations under 21 CFR part 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1020235
- Company Name: Intarcia Therapeutics, Inc.
- Inspection Date: 2017-08-03
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Project Area: New Drug Evaluation
- Product Type: Human Drugs
- Center: Human Drugs
- Office Name: San Francisco District Office
- Citation Count: 9

## Related Officers

- [Ashar P. Parikh](https://www.keypedia.com/people/ashar-p-parikh/f5430c51-31c7-44bb-90f7-1ec8ae581343)
- Issuing Officer
- [Eileen A. Liu](https://www.keypedia.com/people/eileen-a-liu/fa051db4-1242-4181-9af9-5b3cd2de5689)
- [FDA Associated Person](https://www.keypedia.com/people/james-a-lane/f6cd3d8d-7de9-45c5-9380-7e0c5de4720e)

Company: https://www.keypedia.com/companies/intarcia-therapeutics-inc/e37484a6-8e78-4d81-ade5-e94a83eb2a12

Office: https://www.keypedia.com/offices/san-francisco-district-office/6f838e9c-aae1-4665-9c46-a51d43be02df